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1. Summary 
Dietary supplements are formulations which contain pharmacologically active 
phytochemicals. In recent years, the use of alternative and complementary medicine (CAM) has 
increased significantly. As herbal supplement manufacturers aren’t obligated to undergo extensive 
regulation, the possibility of herb-drug interactions is increased when compared with the likelihood 
of interactions between two prescription drugs. There is a common misconception that because 
herbal supplements are derived from plants, they are safer because they are ˝natural˝. Commonly, 
it is difficult to determine the offending substance in herb-drug interactions, particularly when it 
takes place in patients who are prescribed several different medications. 
Here, we will review the most common herbs involved in herb-drug interactions, as well 
as the results of search criteria involving these interactions. 
2. Sažetak 
 Dodaci prehrani mogu sadržavati farmakološki aktivne tvari. U posljednjih nekoliko 
godina, korištenje alternativne medicine, biljnih lijekova, i dodataka prehrani se znatno povećalo. 
Budući da dodaci prehrani nisu pod nadzorom proizvodnje, mogućnost interakcija između 
dodataka i lijekova je znatno povećana naspram interakcija između lijekova. Postoji česta zabluda 
da su biljni lijekovi sigurni zbog toga što su proizvedeni od takozvanih ˝prirodnih˝ biljaka. 
Često je teško doprijeti do tvari koja je dovela do interakcije u pitanju, pogotovo kad je 
polifarmacija u pitanju.  
U ovom radu će se propitati najčešći preparati uključeni u česte interakcije između biljnih preparata 
i lijekova, kao i rezultati internet-tražilica koje uključuju te interakcije. 
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3. Preface 
 
3.1 Introduction 
In recent years, the use of alternative and complementary medicine (CAM) has increased 
significantly. With the advancement of medicine and the fields it encompasses, new treatments 
have been developed, and previous treatments have improved substantially. In some cases, modern 
medicine falls short of expectations and patients become dissatisfied. In an effort to improve their 
health, they seek alternative treatment. In other cases, patients simply wish to improve their health 
with supplements.   
Unfortunately, this carries with it the possibility of interactions between prescribed drugs 
and over-the-counter supplements.  
Dietary supplements are defined by the Dietary Supplement and Health Education Act (DSHEA) 
of 1994 (1) and include such products as herbals, vitamins, minerals, sports nutrition supplements, 
weight management products, specialty supplements and other oral dosage forms intended to 
supplement the diet (2). 
Dietary supplements are formulations which may contain pharmacologically active 
phytochemicals. These are generally extracted from a variety of plant sources, and can be obtained 
in various formulations. Most commonly, they are purchased as extracts in capsules, but are also 
available as powders, teas, and other ingestible forms. Some can be found as the active ingredients 
in nutrition bars or sports performance drinks.  
Herbal supplements usually have many active phytochemical constituents. Therefore, the 
possibility of interactions is increased when compared with the likelihood of interactions between 
two prescription drugs (3). Presently, most herbal drug interactions are documented as case series 
or individual case reports (4). 
There is a common misconception that because herbal supplements are derived from plants, 
they are safer because they are ˝natural˝. Unfortunately, the Food and Drug Administration (FDA) 
does not regulate dietary supplements in the same was it regulates prescription medications and 
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food additives. Dietary supplement manufacturers are not obliged to follow good manufacturing 
practices (GMP) as are pharmacological companies or food manufacturers. Consequently, the 
products they offer have no reliable levels of their active ingredients or reported additional active 
ingredients which may be a manufacturing by-product and/or impurity.  
The exact pharmacological composition of herbal supplements may fluctuate depending on the 
time of the year the plant was harvested in, the ratio of different plant components, and the 
conditions the plants were grown in. Additionally, when drug-supplement interactions are 
mentioned in case reports, it must be noted that these interactions may be a result of additives, 
inactive ingredients, or trace amounts of other herbs.  
Testing of the quality of more than 1200 dietary supplement products by the independent 
laboratory ConsumerLab.com found that 1 in 4 dietary supplement products lacked the labeled 
ingredients or had other serious problems such as unlisted ingredients or contaminants (5). 
There are currently approximately 20,000 available herbal supplements available on the US 
market. (6). The top 10 most commonly used herbs in the United States are Echinacea, Ginseng, 
Gingko biloba, Garlic, St. John’s wort, Peppermint, Ginger, Soy, Chamomile, and Kava kava. Five 
of the top ten have demonstrated significant evidence showing pharmacological efficacy for 
certain indications. Those include Ginkgo, Garlic, St. John’s wort, Soy, and Kava. However, even 
for these commonly used herbs, the scientific evidence often suffers from poor methodology, 
inconsistent outcome measures, different preparations of the herb, and conflicting results (7).  
It is commonly difficult to determine the offending substance in herb-drug interactions, 
particularly when it takes place in patients who are prescribed several different medications. 
Polypharmacy is emerging as an increasingly important issue with the aging of the world 
population. It is estimated that by the year 2050 the population of people aged more or equal to 60 
years will double and around 400 million people will be more or equal to 80 years of age (8). 
This change in demographics has been enabled with advances in medical technology, diagnostics, 
and treatment. Furthermore, with increasing complexity of therapy comes increased complexity of 
therapy management. Older adults are the biggest consumers of prescription and over-the-counter 
(OTC) medicines (9). As healthcare systems suffer larger patient loads, increased hospitalizations, 
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and protracted hospital stays due to ADRs, possible herb–drug interactions are significant medical 
and financial concerns (10). 
Patients are frequently under the impression that herbal supplements are entirely harmless. In fact, 
most do not even consider herbal supplements as possible culprits when faced with an ADR. 
Additionally, the ADR might be considered to be a novel disease process necessitating further 
therapy with prescriptions intended to mitigate new symptoms. This might further increase the 
number of medications the patient is taking, leading to an even higher incidence of ADRs. 
The first major concern of herbal drug interactions was recognized in 1989 when grapefruit 
juice was reported to increase the blood concentration of felodipine, an anti-hypertensive calcium 
channel antagonist (11). 
Factors which increase the risk of potential important herb-drug interactions are similar to those 
affecting prescription medications. Those are demographic characteristics (such as extremes of 
age, frailty, female gender, mental status, co-morbidities, and hereditary features), 
pharmacological factors (polypharmacy, adjustments in dosage or addition of new medications, 
narrow therapeutic windows, and limitations in elimination pathways) (12).  
 
3.2 Herb-Drug Interactions – Definition 
Herb-drug interactions occur as a result of the same principles as with interactions between 
prescription medications. These are the result of the same pharmacokinetic and pharmacodynamic 
interactions. The interactions presently identified involving prescription drugs and herbs or herbal 
dietary supplements suggest that a number of herbs, most notably St. John’s wort, can alter the 
plasma concentration of a number of common drugs metabolized by CYP, and/or are transported 
by P-gp (13). P-gp is expressed in the intestine, liver, and kidney; it performs an important role in 
the absorption, distribution, or excretion of drugs (14).  
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4. Common Herb-Drug Interactions 
 
4.1 St. John’s wort 
St. John’s wort contains hyperforin, which acts to induce the cytochrome P450 3A4 
(CYP3A4) system, which metabolizes a number of drugs including protease inhibitors, 
cyclosporine, oral contraceptives, irinotecan, warfarin, and digoxin. Failure of antiretroviral 
therapy, transplant rejection, and contraceptive failure have been reported. In addition, St. John's 
wort may produce the serotonin syndrome when taken with other serotonergic medications (15). 
Likewise, treatment failures with a wide variety of agents including anticoagulants, antiretrovirals, 
antifungals, immunosuppressive agents, narcotics, digoxin, and hormonal contraceptives have 
been associated with the concomitant use of St. John's wort due to significant induction of CYP 
1A2, 2C19, 2C9, and 3A4, as well as intestinal P-glycoprotein/MDR-1 drug transporters (16). 
 
4.2 Gingko biloba 
Ginkgo (Ginkgo biloba leaves) is an herb used mainly to treat or prevent memory issues, 
as well as tinnitus and peripheral vascular disease. Its active ingredients ginkgolide, bilobalides, 
and others have antiplatelet activity and have demonstrated platelet-activating factor (PAF) 
receptor antagonist activity (17). Thus, ginkgo has been indicated to be a possible cause of 
postoperative bleeding (18, 19). Some case reports have suggested that patients taking drugs 
affecting platelet function and/or coagulation effects, such as warfarin or the NSAIDs aspirin 
(acetylsalicylic acid), ibuprofen or rofecoxib, experienced bleeding after self-prescribing ginkgo 
(1786 Izzo & Ernstª 2009) at recommended doses (20, 21, 22). Adverse events were especially 
severe for aspirin (reports of spontaneous hyphema) (23), warfarin (intracerebral haemorrhage (24) 
and ibuprofen (comatose state with an intracerebral mass bleeding of which the patient died) (21). 
Conversely, recent trials did not substantiate these outcomes. In one trial (25), ginkgo was found 
to potentiate the effect of cilostazol on bleeding time, however, no substantial association between 
bleeding time prolongation and platelet aggregation inhibition was determined. A systematic 
review of case reports established that ‘‘the causality between ginkgo intake and bleeding is 
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unlikely’’ (26). The effect of ginkgo on CYP enzymes has been evaluated in clinical trials using, 
as probe drugs, alprazolam, midazolam, nifedipine (CYP3A4), caffeine (CYP1A2), chlorzoxazone 
(CYP2E1), debrisoquine (CYP2D6), tolbutamide, diclofenac, flurbiprofen (CYP2C9) and 
omeprazole (CYP2C19) (27, 28, 29, 30, 31, 32, 33, 34). Despite varying results, particularly for 
the CYP3A4 isoform, an effect on CYP enzymes by ginkgo seems questionable. The CYP2C19 
isoform is a notable exception.  
The idea that the combination of ginkgo and anticoagulant or antiplatelet drugs may correspond to 
a serious health risk is based on a number of case reports. Nonetheless, these findings were not 
substantiated by clinical trials. Ginkgo should be not taken concomitantly with CYP2C19 
substrates, while the effect of ginkgo on CYP3A4 warrants further study. 
 
4.3 Echinacea 
Echinacea is a widely used herb, usually for the prevention and treatment of upper 
respiratory tract infections. It is formulated from plants belonging to the genus Echinacea, 
including E. purpurea, E. angustifolia and E. pallida (Fam Asteraceae). These varieties have 
phytochemical resemblances, but also noteworthy differences, particularly regarding the distinct 
alkylamides and their concentration, which are chemical constituents which are capable of 
modulating cytochrome P450 (CYP) activity. Used alone, echinacea is considered to be innocuous, 
with little risk for the consumer (35).  
Reports regarding the effect of echinacea on CYP activity have shown conflicting results. 
Gorski et al. found that echinacea (E. purpurea roots), taken as1600 mg/day for 8 days, decreased 
the oral clearance of CYP1A2 substrates (but not the oral clearance of CYP2C9 and CYP2D6 
substrates), as well as caused selective modulation of the catalytic activity of CYP3A4 at hepatic 
and intestinal sites in healthy volunteers (36). However, two other trials found no effect of 
echinacea on CYP1A2, CYP2D6, CYP2E1 or CYP3A4 (37, 38). 
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4.4. Garlic 
Aside from culinary uses, garlic (Allium sativum L., Fam Liliaceae) is used as a 
medicinal herb for the treatment of hypercholesterolemia and the prevention of atherosclerosis. It 
has been suggested that garlic may exhibit an effect on platelet function and coagulation 
properties, which could lead to an increased risk of bleeding (39). In two patients previously 
stabilized on warfarin, the international normalized ratio (INR) changed after garlic intake 
according to one publication (40). However, two trials stated that garlic (enteric-coated tablets or 
aged garlic extract) made no alterations to the pharmacokinetics or pharmacodynamics of 
warfarin, and that garlic presents no serious hemorrhagic risk in sufficiently monitored patients 
on warfarin therapy (41, 42).  Two clinical trials suggested that garlic oil may selectively inhibit 
CYP2El, as demonstrated by the decreased 6-hydroxychlorzoxazone/chlorzoxazone serum ratios, 
although not other CYP isoforms (such as CYPlA2, CYP3A4 or CYP2D6) (27, 28). Garlic 
powder demonstrated no effect on CYP3A4 (43, 44). Garlic may cause interactions in patients on 
antiretroviral therapy (39). A substantial decrease in the plasma concentrations of saquinavir, a 
protease inhibitor, was seen in healthy volunteers after taking garlic for 3 weeks (45). Acute 
dosing of garlic over 4 days did not considerably modify the single-dose pharmacokinetics of the 
protease inhibitor ritonavir (a CYP3A4 and P-glycoprotein substrate) (46). The reason for these 
incongruities is presently unclear.  
Lastly, a clinical trial indicated that chewed raw garlic meaningfully reduced cholesterol 
and triglyceride levels, but did not significantly reduce serum cyclosporine levels in renal 
transplant recipients (47). Caution is recommended if garlic is taken along with CYP2El 
substrates or with antiretroviral drugs such as ritonavir and saquinavir. The likelihood of garlic 
causing over anticoagulation if administered concomitantly with anticoagulant drugs has not 
been established by clinical trials (41, 42). 
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4.5 Kava kava 
Kava is a frequently encountered herb used to treat anxiety. Despite approximately 80 
reported cases of possible hepatotoxicity, kava (Piper methysticum roots and rhizome) is 
enduringly popular (48). Clinical studies have demonstrated that kava exhibits an inhibitory effect 
on CYP2EI, however it did not show the same effect on other CYP isoforms, such as CYP3A4, 
CYP2D6 or CYPIA2, or P-glycoprotein (38). Individual case reports have indicated interactions 
of kava with levodopa, the antiparkinsonian drug, with consequent reduced efficacy (49), as well 
as with the alprazolam, a benzodiazepine, causing a semi-comatose state (50). These findings 
might have a pharmacodynamic basis, as kava is an antagonist of dopamine effects, which may 
elucidate the diminished efficacy of levodopa.  
Kava may also interact with GABA receptors, much like with benzodiazepines (51). 
Therefore, kava should be not taken along with CYP2EI substrates, nor should it be taken with 
dopaminergic drugs or benzodiazepines. 
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5. Hypothesis 
Based on a recent resurgence of popularity of ˝natural medicine˝ and ˝alternative 
medicine˝, we hypothesize that the trends of interest in herb-drug interactions over time will 
increase. We also hypothesize that herbal remedies will show an upward trend in internet-based 
search.  
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6. Objectives 
The objective of this study is to determine the clinical relevance of common interactions 
of drugs and herbal supplements used in alternative medicine through public interest and 
knowledge of such interactions.  
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7. Material and Methods 
The most frequently used herbs were used as keywords in the search criteria. We decided 
to incorporate Google Trends in our study to gain insight into patient behavior. Google Trends is 
an internet-based tool used to statistically analyze search data. Google Trends provides access to 
Internet search patterns by analyzing a portion of all web queries on the Google Search website 
and other affiliated Google sites (52). A description of the user interface is shown in Figure S1. 
Users can download the output of their searches to conduct further analyses. The portal determines 
the proportion of searches for a user-specified term among all searches performed on Google 
Search. It then provides a relative search volume (RSV), which is the query share of a particular 
term for a given location and time period, normalized by the highest query share of that term over 
the time-series (53, 54). 
The data we sought to analyze was patient interest in supplements, supplement-drug 
interactions, and how public interest in these has changed over time. We also used Google Trends 
to compare public interest in specific search key words and phrases. 
However, there is limited information on possible ways to utilize it, as well as its 
limitations. Filters applied to the search were ˝worldwide˝, ˝2004-present˝, ˝all categories˝, and 
˝web search˝. The keywords and search terms used were ˝herb–drug interaction˝, ˝st. john’s wort˝, 
˝st. john’s wort interactions˝, ˝garlic interactions˝, ˝gingko interactions˝, ˝herbal remedies˝, and 
˝herb – treatment interaction˝. 
Comparisons between ˝alternative medicine˝ and ˝evidence-based medicine˝ on Google 
Trends and follow up searches were done on Google for news articles. The search term used was 
˝death herbal drug˝. The results included a recommendation that claimed people also searched for 
˝deaths due to herbal supplements˝. This term was searched to see if there were any major news 
stories between 2004 and the present. An article titled ˝ Herbal medicines can be deadly, pathologist 
warns˝ was found on Science Daily (55). The article reported a study emphasizing the potential 
dangers of herbal supplements including examples of such complications.  
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8. Results 
 
Despite herbal remedies being consistently searched as a term on the Google Trends search 
engine over time, we were surprised to find that the term ˝herb-drug interaction˝ produced no 
results. Likewise, no results appeared for the search terms: ˝St. John’s wort-drug interactions˝, ˝st. 
john’s wort˝, ˝st. john’s wort interactions˝, ˝garlic interactions˝, ˝gingko interactions˝, or ˝herb – 
treatment interaction˝. ˝herbal remedies˝ showed a persistent decline from 2004-present. 
The comparison of ˝st. john’s wort interactions˝ vs. ˝warfarin interactions˝ showed zero 
results for St. John’s wort interactions, compared to warfarin, which showed consistent searches 
with steady variability. 
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Screenshot 1. Google Trends ˝alternative medicine˝ vs. ˝evidence based medicine˝ 
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Screenshot 2. Google Trends ˝herb – treatment interaction˝ 
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Screenshot 3. Google Trends ˝herbal remedies˝ 
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Screenshot 4. Google Trends ˝gingko interactions˝ 
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Screenshot 5. Google Trends ˝garlic interactions˝ 
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Screenshot 6. Google Trends ˝st. john’s wort interactions˝ 
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Screenshot 7. Google Trends ˝st. john’s wort˝ 
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Screenshot 8. Google Trends ˝st. john’s wort interactions˝ vs. ˝warfarin interactions˝ 
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9. Discussion 
The data obtained was worrisome. In fact, we were astounded by the results. Obviously, 
Google Trends is a novel data collection tool and there is clearly a degree of error in the available 
data.  
It is also important to note that there are limitations in the methodology used. Many 
different terms were applied to Google Trends to determine if there was any correlation between 
news articles regarding complications stemming from herbal supplement use. Even though none 
of these terms or phrases showed correlations between news stories and subsequent searches, that 
does not definitely rule out that such searches had not taken place. Specific terms/phrases might 
exist that do indeed show a correlation between adverse events in the news and searches on the 
internet.  
The supposed lack of self-education of the general public on the use of herbal supplements 
emphasizes how important it is for the medical community to step in. An estimated 30% of US 
citizens use herbal supplements, often without their doctor's knowledge (55). This indicates that 
the medical community should be proactive in discussing the use of herbal supplements with 
patients. Herbal supplements have a reputation of being safe because they are ˝ natural˝, but because 
there is virtually no regulation of their development, it is possible they can be anything but safe.  
The Science Daily article referencing the dangers of herbal supplements was published in 
February of 2010. It is clear it's publication had little effect on increasing search terms referencing 
the dangers of herbal medicine as there is no appreciable changes seen in Google Trends in 
February 2010. In fact, when the phrase ˝death due to herbal supplements˝ was put into Google 
Trends, there was no data to be shown. This was concerning, as the term was recommended by 
Google as a phrase searched for in the past. 
Educating patients on the topic should be done carefully so as not to alienate or upset them. 
Some patients might feel their autonomy is being threatened if they are criticized for using herbal 
supplements or feel the doctor has ulterior motives if they recommend terminating the use of a 
supplement.  
It is important to point out that there is not only an increasing level of trust in herbal 
medicine but there is a concomitant decrease of trust in western medicine. A major factor that is 
23 
 
allowing the disbalance to occur simultaneously is the use of social media. Social media has the 
power to allow anecdotal stories to be used as proof that alternative therapies that are less harmful 
exist.  
The British Academy of Royal Sciences conducted a survey in 2017 that showed only 37 
percent of Britons believed evidence from medical research (56). Furthermore, roughly two thirds 
of those respondents felt family and friends are the most reliable sources for medical advice. The 
direct effect of this lack of trust can be correlated to the lack of knowledge of interactions between 
herbal therapies and western medicine. 
A focus on evidence-based knowledge of certain supplements exists and that information 
should be shared neutrally. Also, any quality-control studies on specific products should be 
researched by the doctors and shared with the patients so at least they will know to avoid those 
particular brands. 
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10. Conclusions 
 
The results of our analysis suggest that the popularity and on-line public search for 
knowledge of interactions between drugs and herbal supplements used in alternative medicine is 
indicative of the insidious, seemingly benign nature of herbal remedies used concurrently with 
prescription drugs. It is obvious that patients view herbal supplements as harmless additions to 
their health regimen, as evidenced by a lack of interest into potential harmful effects or 
interactions.  
Google Trends is an undoubtedly useful tool in the analysis of commonly searched (or 
uncommonly searched) data. We believe there is much improvement to made in regard to the 
reliability of available data analysis, and look forward to seeing them implemented.  
 
Regarding the use of herbal supplements, manufacturing companies must be held responsible to 
determine what possible interactions their products might be involved in and present clear 
statements regarding their results. It is essential to provide regulation to better control what herbal 
supplements contain and their exact composition. Furthermore, an interaction reporting domain 
must be put into place in order to facilitate reporting of instances of interactions.  
 
We recommend that popular search engines (i.e. Google) should display a warning 
message about potential drug interactions when searching for alternative medicine compounds. 
Care must be taken by physicians to inquire of their patient’s herbal supplement usage, as 
well as discuss herbal supplements with patients. Furthermore, physicians should familiarize 
themselves with common herb-drug interactions so as to better provide information to their 
patients. This should be devoid of judgement, as the data shown here ascertains that patients will 
demonstrate interest in supplements regardless of whether or not they choose to disclose this 
information with their physician. 
There is a need for more formal, human-subject studies to gain better knowledge of the 
prevalence of specific herb-drug interactions.  
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